Residual disease detection using targeted parallel sequencing predicts relapse in cytogenetically normal acute myeloid leukemia
Explore this paper's citation graph
- Type
- article
- Published
- 2018-01-01
- Cited by
- 16
- References
- 44
- Access
- Open access
- OpenAlex
- https://openalex.org/W28960408
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:34754939
Keywords
Lead–acid battery, State of charge, Electrolyte, Electrochemistry, Electrode
References
- Interleukin-4 Stimulates Proliferation and Growth of T-Cell Acute Lymphoblastic Leukemia Cells by Activating mTOR Signaling
- Preexisting TP53 mutation in therapy-related acute myeloid leukemia
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia
- BRAF mutations are very rare in B- and T-cell pediatric acute lymphoblastic leukemias
- The Feasibility Study of Non-Invasive Fetal Trisomy 18 and 21 Detection with Semiconductor Sequencing Platform
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
- Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult acute myeloid leukemia.
- How I treat acute myeloid leukemia.
- Bone marrow aspiration technique may have an impact on therapy stratification in children with acute lymphoblastic leukaemia
- Role of DNMT3A, TET2, and IDH1/2 Mutations in Pre-Leukemic Stem Cells in Acute Myeloid Leukemia
- Integrative Genomics Viewer
- Risk stratification of intermediate-risk acute myeloid leukemia: integrative analysis of a multitude of gene mutation and gene expression markers.
- Monitoring of residual disease by next-generation deep-sequencing of RUNX1 mutations can identify acute myeloid leukemia patients with resistant disease
- The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach
- Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia: results from cancer and leukemia group B study 8461.
- Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting system.
- A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff
- Therapeutic advances in acute myeloid leukemia.
- Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
Cited by
- Targeted RNA-sequencing for the quantification of measurable residual disease in acute myeloid leukemia
- Molecular Measurable Residual Disease Testing of Blood During AML Cytotoxic Therapy for Early Prediction of Clinical Response
- Accurate and Sensitive Analysis of Minimal Residual Disease in Acute Myeloid Leukemia Using Deep Sequencing of Single Nucleotide Variations.
- Minimal/Measurable Residual Disease Monitoring in NPM1-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives
- Genetic Hierarchy of Acute Myeloid Leukemia: From Clonal Hematopoiesis to Molecular Residual Disease
- High GPR56 surface expression correlates with a leukemic stem cell gene signature in CD34‐positive AML
- Prognostic impact of circulating tumor DNA status post-allogeneic hematopoietic stem cell transplantation in AML and MDS.
- Loss of RAF kinase inhibitor protein is involved in myelomonocytic differentiation and aggravates RAS-driven myeloid leukemogenesis
- Next‐generation sequencing for measurable residual disease detection in acute myeloid leukaemia
- Sensitive and broadly applicable residual disease detection in acute myeloid leukemia using flow cytometry‐based leukemic cell enrichment followed by mutational profiling
- Targeted Next-Generation Sequencing of Circulating Tumor DNA, Bone Marrow, and Peripheral Blood Mononuclear Cells in Pediatric AML
- Accurate Detection of Subclonal Variants in Paired Diagnosis-Relapse Acute Myeloid Leukemia Samples by Next Generation Duplex Sequencing
- Measurable Residual Disease Detection in Acute Myeloid Leukemia: Current Challenges and Future Directions
- Minimal Residual Disease Detection: Implications for Clinical Diagnosis and Cancer Patient Treatment
- Flow cytometric and molecular MRD in AML: current methods, clinical applications and challenges
- Landscape of Measurable Residual Disease in Acute Myeloid Leukemia: From Molecular Detection to Clinical Practice
Related papers
- Techniques for estimating the state-of-charge of lead acid batteries in electric vehicles
- Estimation of State-of-Charge of Lead-Acid Batteries Using Electrochemistry Theorem
- Estimating the residual range of motorcycles powered by lead acid batteries
- Estimating the state of charge of a battery
- A battery equivalent-circuit model and an advanced technique for parameter estimation
- Model based state of charge estimation method for ultra-capacitor
- Research on the charge model of lead-acid batteries onboard modern submarines
- High resolution state of charge estimation in electrochemical batteries
- State of charge estimator for NiMH batteries